Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoni Kong

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Liver Research|February 17, 2025
Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectivesYuling Luan, Xiaoni Kong, Yu Feng
Cancer Drug Resistance (Alhambra, Calif.)|May 9, 2025
Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformationJinglu Yu, Xiaoni Kong, Yu Feng
International Journal of Biological Sciences|August 30, 2016
Role of Osteopontin in Liver DiseasesYankai Wen, Seogsong Jeong, Qiang Xia, et al.
Journal of Gastroenterology and Hepatology|July 17, 2013
Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver diseaseXiaoni Kong, Dechun Feng, Stephanie Mathews, et al.
International Journal of Medical Sciences|March 22, 2021
Systematic elucidation of the mechanism of Jingyin granule in the treatment of Novel Coronavirus (COVID-19) Pneumonia via Network PharmacologyBingrui Wang, Xuehua Sun, Xiaoni Kong, et al.
Journal of Ethnopharmacology|December 30, 2024
Icariin maintaining TMEM119-positive microglial population improves hippocampus-associated memory in senescent mice in relation to R-3-hydroxybutyric acid metabolismRong Ma, Yuge Zhou, Weifan Huang, et al.
Journal of Hepatology|May 22, 2018
Protective effects of heme oxygenase 1 during ischemia-reperfusion injury: Hepatocytes or non-parenchymal cells?Dongwei Xu, Min Xu, Xiaoni Kong, et al.
Journal of Immunology Research|September 19, 2019
Immunotherapy of Liver DiseasesDechun Feng, YinYing Lu, Xiaoni Kong, et al.
Frontiers in Physiology|April 12, 2012
Cytokines and STATs in Liver FibrosisXiaoni Kong, Norio Horiguchi, Masatomo Mori, et al.
Pharmacological Research|September 21, 2025
Interleukin-11: A central integrative hub driving pathological progression from pulmonary inflammation and fibrosis to cancerJinglu Yu, Jialong Qi, Xiaoni Kong, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Liver Research|February 17, 2025
Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectivesYuling Luan, Xiaoni Kong, Yu Feng
Cancer Drug Resistance (Alhambra, Calif.)|May 9, 2025
Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformationJinglu Yu, Xiaoni Kong, Yu Feng
International Journal of Biological Sciences|August 30, 2016
Role of Osteopontin in Liver DiseasesYankai Wen, Seogsong Jeong, Qiang Xia, et al.
Journal of Gastroenterology and Hepatology|July 17, 2013
Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver diseaseXiaoni Kong, Dechun Feng, Stephanie Mathews, et al.
International Journal of Medical Sciences|March 22, 2021
Systematic elucidation of the mechanism of Jingyin granule in the treatment of Novel Coronavirus (COVID-19) Pneumonia via Network PharmacologyBingrui Wang, Xuehua Sun, Xiaoni Kong, et al.
Journal of Ethnopharmacology|December 30, 2024
Icariin maintaining TMEM119-positive microglial population improves hippocampus-associated memory in senescent mice in relation to R-3-hydroxybutyric acid metabolismRong Ma, Yuge Zhou, Weifan Huang, et al.
Journal of Hepatology|May 22, 2018
Protective effects of heme oxygenase 1 during ischemia-reperfusion injury: Hepatocytes or non-parenchymal cells?Dongwei Xu, Min Xu, Xiaoni Kong, et al.
Journal of Immunology Research|September 19, 2019
Immunotherapy of Liver DiseasesDechun Feng, YinYing Lu, Xiaoni Kong, et al.
Frontiers in Physiology|April 12, 2012
Cytokines and STATs in Liver FibrosisXiaoni Kong, Norio Horiguchi, Masatomo Mori, et al.
Pharmacological Research|September 21, 2025
Interleukin-11: A central integrative hub driving pathological progression from pulmonary inflammation and fibrosis to cancerJinglu Yu, Jialong Qi, Xiaoni Kong, et al.
Pageof 12